Robert N. Cappucci, a partner of the Firm, received his undergraduate degree from Fordham University, graduating cum laude and in cursu honorum. He received his law degree from Fordham University School of Law, where he was Articles Editor of the Fordham International Law Journal. Mr. Cappucci is also the author of Amending the Treatment of Defense Production Enterprises Under the U.S. Exon-Florio Provision: A Move Toward Protectionism or Globalism?, 16 Fordham Int’l L.J. 652 (1993), which addresses international mergers and acquisitions, discusses the United States Treasury’s Committee on Foreign Investment in the U.S. (CFIUS) and has been cited by the Federal Communications Law Journal in Too Much Power, Too Little Restraint: How the F.C.C. Expands Its Reach Through Unenforceable and Unwieldy “Voluntary” Agreements, 53 Fed. Comm. L.J. 49, 51 (2000). Mr. Cappucci concentrates his practice in the area of securities litigation and supervises the Firm’s client reporting program. He has particular expertise in issues impacting the Firm’s hedge fund and institutional trading firm client base.

Mr. Cappucci’s recent litigation successes include: serving as a member of Co-Lead Counsel in In re Tremont Securities Law, State Law and Insurance Litigation, Case No. 1:08-cv-11117 (S.D.N.Y.) (resulting in the distribution of proceeds based upon a $2.9 billion claim in the Bernard L. Madoff Investment Securities (“BLMIS”) bankruptcy and recovery of more than $100 million in additional settlements); and acting as a member of Co-Lead Counsel in Paul Shapiro v. J.P. Morgan Chase & Co., Case Nos. 11 Civ. 8331 (CM)(MHD) and 11 Civ. 7961 (CM) (S.D.N.Y) (resulting in the settlement of class, clawback and regulatory claims worth $2.243 billion). Mr. Cappucci was also one of a handful of attorneys granted access to Bernard Madoff post-sentencing, at which time Mr. Cappucci personally interviewed Madoff in order to obtain further admissions regarding the BLMIS Ponzi scheme. Most recently, in In re Allergan, Inc. Proxy Violation Securities Litigation, Case No. 8:14-cv-02004-DOC-KES (C.D. Cal.), Mr. Cappucci was instrumental in securing a $40 million settlement from Valeant Pharmaceuticals International, Inc., Pershing Square Capital Management, L.P. and related defendants on behalf of investors in Allergan derivative instruments that were damaged by the defendants’ alleged insider trading scheme.

Mr. Cappucci is a member of the Commercial and Federal Litigation Sections of the New York State Bar Association and a member of the American Bar Association, Federal Bar Council, Association of the Bar of the City of New York and Association of Trial Lawyers of America.

Before entering private practice, Mr. Cappucci interned with the Honorable John E. Sprizzo, United States District Court, Southern District of New York.